A Prospective Study to Monitor for Tuberculosis During Anti-tumour Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease and Immune-mediated Inflammatory Diseases

Biologic therapies have revolutionised the treatment of immune-mediated diseases including inflammatory bowel disease [IBD] and rheumatological disorders. However, biologic treatments are associated with an increased risk of reactivation of latent tuberculosis. Data from regular monitoring for laten...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of Crohn's and colitis 2018-07, Vol.12 (8), p.954-962
Hauptverfasser:	Lee, Choon Kin, Wong, Sunny H V, Lui, Grace, Tang, Whitney, Tam, Lai San, Ip, Margaret, Hung, Esther, Chen, Minhu, Wu, Justin C, Ng, Siew C
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antirheumatic Agents - therapeutic use Antitubercular Agents - therapeutic use Biological Therapy Female Gastrointestinal Agents - therapeutic use Humans Immunosuppressive Agents - therapeutic use Inflammatory Bowel Diseases - drug therapy Interferon-gamma Release Tests Isoniazid - therapeutic use Latent Tuberculosis - diagnosis Latent Tuberculosis - drug therapy Male Middle Aged Prospective Studies Radiography, Thoracic Rheumatic Diseases - drug therapy Rheumatic Diseases - immunology Risk Factors Tuberculin Test Tumor Necrosis Factor-alpha - antagonists & inhibitors Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!